Glanville A R, Tazelaar H D, Theodore J, Imoto E, Rouse R V, Baldwin J C, Robin E D
Department of Medicine, Stanford University School of Medicine, California.
Am Rev Respir Dis. 1989 Feb;139(2):330-4. doi: 10.1164/ajrccm/139.2.330.
The distribution and degree of expression of Class I and Class II major histocompatibility (MHC) antigens on human lower respiratory tract epithelium were evaluated in five freshly obtained pneumonectomy and lobectomy specimens using an immunoperoxidase technique. Multiple sites were examined from each specimen, and two independent observers graded each sample as positive, equivocal, or negative compared with control slides. Interobserver agreement was high. From a total of 120 grade determinations, 114 showed complete concordance and only one showed a positive/negative discordance. Both Class I (HLA-A,B,C) and Class II (HLA-DR) antigens were uniformly and strongly expressed throughout the major, lobar, and segmental bronchi of each sample, the bronchiolar epithelium, and the alveolar epithelium. Paired samples of adjacent lower respiratory tract epithelium harvested with the fiberoptic bronchoscope and during pathologic examination, respectively, revealed an identical staining pattern for these antigens. Staining for HLA-DQ expression (a subset of MHC Class II antigens) was generally weaker and appeared more variable, with four negative, six equivocal, and 30 positive samples. Our observations demonstrate the widespread expression of Class I antigens on airway epithelium and reveal for the first time the ubiquitous nature of Class II MHC antigen (HLA-DR) expression throughout the lower respiratory tract. Furthermore, they attest to the adequacy of bronchoscopically obtained samples for immunologic staining. These results provide a basis for both a putative mechanism of bronchocentric rejection phenomena after human heart-lung transplantation and for the means to monitor it prospectively.
采用免疫过氧化物酶技术,在5份新鲜获取的肺叶切除和肺段切除标本中,评估了I类和II类主要组织相容性复合体(MHC)抗原在人下呼吸道上皮的分布及表达程度。对每个标本的多个部位进行了检查,与对照玻片相比,两名独立观察者将每个样本分为阳性、可疑或阴性。观察者间的一致性很高。在总共120次分级判定中,114次显示完全一致,只有1次显示阳性/阴性不一致。I类(HLA - A、B、C)和II类(HLA - DR)抗原在每个样本的主支气管、叶支气管和段支气管、细支气管上皮及肺泡上皮中均呈均匀且强表达。分别通过纤维支气管镜和病理检查获取的相邻下呼吸道上皮的配对样本,显示这些抗原的染色模式相同。HLA - DQ表达(MHC II类抗原的一个子集)的染色通常较弱且变异性更大,有4个阴性样本、6个可疑样本和30个阳性样本。我们的观察结果表明I类抗原在气道上皮广泛表达,并首次揭示了II类MHC抗原(HLA - DR)在下呼吸道普遍存在的特性。此外,它们证明了通过支气管镜获取的样本用于免疫染色的充分性。这些结果为人类心肺移植后支气管中心性排斥现象的推测机制及前瞻性监测手段提供了依据。